1.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CHRS Giù?
Forum
Previsione
Coherus Oncology Inc Borsa (CHRS) Ultime notizie
3 Penny Stocks With Market Caps Over $80M To Consider - simplywall.st
Coherus Oncology's (NASDAQ:CHRS) investors will be pleased with their solid 132% return over the last year - Yahoo Finance
Can Coherus Oncology Inc. (8C5) stock retain market dominanceMarket Activity Report & Long-Term Safe Investment Plans - newser.com
Will Coherus BioSciences Inc. stock recover faster than marketBuy Signal & Breakout Confirmation Trade Signals - newser.com
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Coherus Oncology (NASDAQ: CHRS) schedules Nov. 6 results release and 5 p.m. ET call - Stock Titan
CapEx per share of Coherus Oncology, Inc. – DUS:8C5 - TradingView
Coherus Oncology, Inc. (NASDAQ:CHRS) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Coherus Oncology (CHRS) to Release Quarterly Earnings on Wednesday - MarketBeat
How Coherus Oncology Inc. (8C5) stock performs during market turbulenceLayoff News & Scalable Portfolio Growth Methods - newser.com
Despite shrinking by US$22m in the past week, Coherus Oncology (NASDAQ:CHRS) shareholders are still up 122% over 1 year - simplywall.st
Aug Ideas: How Coherus Oncology Inc. (8C5) stock performs during market turbulenceJuly 2025 Retail & Consistent Profit Trading Strategies - Fundação Cultural do Pará
Coherus Oncology (NASDAQ:CHRS) Given "Sell (D)" Rating at Weiss Ratings - MarketBeat
Will Coherus BioSciences Inc. stock deliver better than expected guidanceLayoff News & Real-Time Volume Surge Alerts - newser.com
Coherus Oncology (NASDAQ:CHRS) Share Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
What analysts say about Coherus Oncology Inc 8C5 stockStock Buy Signals & Maximum Profit Growth - earlytimes.in
Will Coherus Oncology Inc. (8C5) stock benefit from infrastructure billPortfolio Risk Report & Risk Controlled Swing Trade Alerts - newser.com
Coherus Oncology to Participate in Upcoming Investor Conferences - The Manila Times
Will Coherus Oncology Inc. (8C5) stock outperform value peersBuy Signal & Community Verified Trade Alerts - newser.com
Lobbying Update: $80,000 of COHERUS BIOSCIENCES INC. lobbying was just disclosed - Quiver Quantitative
What dividend safety rating applies to Coherus Oncology Inc. (8C5) stock2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
Why Coherus Oncology Inc. (8C5) stock is trending on social media2025 Geopolitical Influence & Long Hold Capital Preservation Tips - newser.com
Guidance Update: Will Coherus Oncology Inc. (8C5) stock outperform value peersJuly 2025 Momentum & Long-Term Growth Portfolio Plans - nchmf.gov.vn
Stock Market Recap: Will Coherus Oncology Inc. (8C5) stock outperform value peersJuly 2025 Trends & Technical Pattern Recognition Alerts - Trung tâm Dự báo KTTV quốc gia
CHRS (Coherus Oncology) EBITDA Margin % : -405.39% (As of Jun. 2025) - GuruFocus
Coherus Oncology, Inc.Common Stock (Nasdaq:CHRS) Stock Quote | Oklahoma City NewsThe Oklahoman - FinancialContent
How Coherus Oncology Inc. (8C5) stock reacts to monetary easing2025 Dividend Review & Real-Time Market Trend Scan - newser.com
Coherus Oncology (NASDAQ:CHRS) Share Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
What technical patterns form on Coherus Oncology Inc. (8C5) stock chartsMarket Sentiment Review & Weekly Return Optimization Plans - newser.com
Revenue per share of Coherus Oncology, Inc. – MUN:8C5 - TradingView
4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals - inkl
How strong dollar benefits Coherus Oncology Inc. (8C5) stockJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-10-06 04:13:27 - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):